Medipharm Labs Corp Capital Reinvestment Ratio
Medipharm Labs Corp capital reinvestment ratio. Medipharm Labs Corp (LABS) has a Capital Reinvestment Ratio of 0.23x as of December 2025, meaning it reinvests 0% of its operating cash flow (CA$435.00K) in capital expenditures (CA$100.00K). Check Medipharm Labs Corp investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Medipharm Labs Corp (2017–2017)
Capital reinvestment ratio of Medipharm Labs Corp from 2017 to 2017. This chart tracks Medipharm Labs Corp's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset momentum of Medipharm Labs Corp to track the company's year-over-year net asset growth rate.
Medipharm Labs Corp Capital Reinvestment Ratio by Year (2017–2017)
Medipharm Labs Corp capital reinvestment ratio by year from 2017 to 2017. For the full cash flow conversion analysis, see LABS cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 12.92x | CA$166.00K | CA$2.14 Million | — |